OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Gastric Polyps reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,234 reports · 53 co-occurring drugs

As of the last recalculation, Gastric Polyps appears in 2,234 FAERS reports alongside 53 co-occurring drug terms. The strongest observed disproportionality signal is OLMESARTAN MEDOXOMIL (PRR 39.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Olmesartan Medoxomil14239.239.4
Teduglutide3927.427.5
Isosorbide Mononitrate4822.022.1
Dextrose2920.820.8
Dextrose Monohydrate2920.520.5
Rabeprazole4318.418.4
Vortioxetine3117.217.2
Cholestyramine2217.117.1
Sucralfate4216.616.7
Esomeprazole Magnesium33915.715.8
Esomeprazole Magnesium Capsule, Delayed Release2415.615.6
Esomeprazole Magnesium Delayed Release Capsules2415.615.6
Esomeprazole Magnesium Dihydrate2415.515.5
Esomeprazole9014.014.1
Felodipine Extended-Release Tablets1512.312.4
Felodipine1512.312.4
Hydroxyzine Hydrochloride1611.411.4
Hydroxyzine Hydrochloride Oral1611.411.4
Torsemide3810.910.9
Sucralfate Oral1610.610.6
Sucralfate Oral Suspension1610.510.5
Hyoscyamine Sulfate1010.210.2
Isosorbide Dinitrate209.69.6
Hydroxyzine479.49.4
Rabeprazole Sodium279.39.3
Donepezil Hydrochloride369.39.3
Metoclopramide539.29.2
Dexlansoprazole378.48.4
Metoclopramide Hydrochloride678.38.3
Pitavastatin Calcium98.28.2
Omeprazole Magnesium3378.18.1
Lansoprazole1377.67.6
Candesartan Cilexetil217.57.5
Tolvaptan117.17.1
Omeprazole2377.07.0
Misoprostol76.76.7
Linagliptin136.76.7
Dabigatran Etexilate536.56.5
Rifaximin146.36.3
Valsartan And Hydrochlorothiazide85.55.5
Tramadol Hydrochloride215.25.2
Sitagliptin And Metformin Hydrochloride125.25.2
Epoprostenol75.05.0
Prasugrel Hydrochloride54.64.6
Riociguat154.34.3
Alpelisib44.34.3
Apixaban304.24.2
Macitentan304.14.1
Dapagliflozin133.93.9
Vedolizumab333.63.6
Iohexol33.43.4
Methoxy Polyethylene Glycol-Epoetin Beta32.52.5
Tafamidis32.42.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.